Marcum LLP
Insights

Healthcare Alert

 

In This Edition

Illinois' Medicaid Program Advanced Cloud Technology (IMPACT) Revalidation Updates

Share:

Last summer the State of Illinois announced the launch of their new Medicaid Management Information System (MMIS) known as Illinois' Medicaid Program Advanced Cloud Technology (IMPACT). In order to transition to the new information system, billing agents, billing providers, and individuals rendering or servicing Medicaid individuals were required to revalidate their information in the new IMPACT system.

Providers who failed to revalidate their data by September 24, 2016, will be terminated from Medicaid on February 1, 2017. To re-enroll in the Medicaid program, terminated providers will be required to submit a new Medicaid provider enrollment in IMPACT. The date the new enrollment application is submitted will be the earliest date that the provider will be able to begin submitting claims and encounter data to the state. Providers who have an application in review status, will not be terminated. For additional information on the IMPACT integration, including contact information, you may visit the State's website.

If you need assistance with the revalidation or enrollment process, please contact your Marcum LLP advisor at 847-282-6300.

 
 
 
 
HAVE A QUESTION? ASK MARCUM
 
STAY IN TOUCH.

SIGN UP TODAY FOR MARCUM'S NEWSLETTERS.

ABOUT MARCUM LLP

Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation, with offices in major business markets throughout the U.S., as well as Grand Cayman, China and Ireland.

Learn More

CONNECT WITH US
OFFICES

Headquarters
750 3rd Avenue, 11th Floor
New York, NY 10017

Find an Office

(855) MARCUM1
info@marcumllp.com

FOUNDATION

Marcum Foundation

AFFILIATIONS

Leading Edge Alliance

Privacy Policy

This website uses cookies to learn how visitors interact with our website so that we can improve our services and your online experience. By using this website, you agree to our privacy policy.